Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 5, 2004, Pages 279-284

  Schleier, Peter ^a   Hyckel, Peter ^a   Berndt, Alexander ^a   Bode, Hans Peter ^b   Albrecht, Volker ^b   Hindermann, Winfried ^a   Kosmehl, Hartwig ^c   Zenk, Witold ^a   Schumann, Dieter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Biolitec AG   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

ALA based photodynamic therapy; Immunosuppression; Organ recipients; Skin tumours

Indexed keywords

AMINOLEVULINIC ACID; LEVULINIC ACID;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; EPITHELIUM TUMOR; FACE; HUMAN; INVASIVE CARCINOMA; IRRADIATION; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECIPIENT; REFRACTORY PERIOD; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FACIAL NEOPLASMS; HUMANS; KERATOSIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REMISSION INDUCTION; SKIN NEOPLASMS; TRANSPLANTS;

EID: 2542439897     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0539-2     Document Type: Article

References (38)

1. Biel MA (2002) Photodynamic therapy in head and neck cancer. Curr Oncol Rep 4:87-96
2. Corti L, Mazzarotto R, Belfontali S, De Luca C, Baiocchi C, Boso C, Calzavara F (1995) Gynecologic cancer recurrences and photodynamic therapy: our experience. J Clin Laser Med Surg 13:325-328
3. Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA (2001) Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 15:550-554
4. Euvrard S, Kanitakis J, Pouteil-Noble C, Claudy A, Touraine JL (1997) Skin cancers in organ transplant recipients. Ann Transplant 2:28-32
5. Fan KF, Hopper C, Speight PM, Buonaccorsi GA, Bown SG (1997) Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer 73:25-32
6. Gagnebin J, Brunori M, Otter M, Juillerat-Jeanneret L, Monnier P, Iggo R (1999) A photosensitising adenovirus for photodynamic therapy. Gene Ther 6:1742-1750
7. Gronlund-Pakkanen S, Pakkanen TM, Koski E, Talja M, Ala-Opas M, Alhava E (2001) Effect of photodynamic therapy on urinary bladder function: an experimental study with rats. Urol Res 29:205-209
8. Harwood CA, Swale VJ, Bataille VA, Quinn AG, Ghali L, Patel SV, Dove-Edwin I, Cerio R, McGregor JM (2001) An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J Invest Dermatol 116:246-253
9. Hyckel P, Berndt A, Wutzler P, Kosmehl H (2001) Tumors of the face in organ transplant patients. Mund Kiefer Gesichtschir 5:94-97
10. Jichlinski P, Leisinger HJ (2001) Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 29:396-405
11. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M (2001) Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2:229-237
12. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL (2000) Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191:561-566
13. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143-148
14. Kick G, Messer G, Goetz A, Plewig G, Kind P (1995) Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res 55:2373-2379
15. Krowka MJ, Wiseman GA, Steers JL, Wiesner RH (1999) Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 5:451-453
16. Lindelof B, Eklund G (1986) Incidence of malignant skin tumors in 14,140 patients after grenz-ray treatment for benign skin disorders. Arch Dermatol 122:1391-1395
17. McGeown MG, Douglas JF, Middleton D (2000) One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre. Clin Transpl 14:193-202
18. Messer G, Rupec RA (2001) Nuclear factor kappa B (NF-kappa B). Function and regulation. Hautarzt 52:677-685
19. Metz JM, Friedberg JS (2001) Endobronchial photodynamic therapy for the treatment of lung cancer. Chest Surg Clin N Am 11:829-839
20. Morris JC, Wildner O (2000) Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Mol Ther 1:56-62
21. Morton CA (2002) The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J Dermatolog Treat 13[Suppl 1]:S25-29
22. Neyts J, Sadler R, De Clercq E, Raab-Traub N, Pagano JS (1998) The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res 58:384-388
23. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, Giercksky KE (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62:906-901
24. Piot B, Rousset N, Lenz P, Eleouet S, Carre J, Vonarx V, Bourre L, Patrice T (2001) Enhancement of delta aminolevulinic acid-photodynamic therapy in vivo by decreasing tumor pH with glucose and amiloride. Laryngoscope 111:2205-2213
25. Reuther T, Kubler AC, Zillmann U, Flechtenmacher C, Sinn H (2001) Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma. Lasers Surg Med 29:314-322
26. Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R (1997) Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B 40:313-319
27. Schleier P, Berndt A, Berndt A, Dahse R, Zenk W, Hyckel P, Kosmehl H (2001) Experimental 5-aminolevulinic acid-induced photodynamic therapy (ALA-PDT) of oral carcinomas. Procedures in treatment of solid tumors and elucidation of cell death. Mund Kiefer Gesichtschir 5:98-104
28. Shackley DC, Briggs C, Gilhooley A, Whitehurst C, O'Flynn KJ, Betts CD, Moore JV, Clarke NW (2002) Photodynamic therapy for superficial bladder cancer under local anaesthetic. BJU Int 89:665-670
29. Sroka R, Beyer W, Gossner L, Sassy T, Stocker S, Baumgartner R (1996) Pharmacokinetics of 5-aminolevulinic-acid-induced porphyrins in tumour-bearing mice. J Photochem Photobiol B 34:13-19
30. Szeimies RM, Landthaler M, Karrer S. Non-oncologic indications for ALA-PDT (2002) J Dermatolog Treat 13[Suppl 1]:S13-18
31. Taylor EL, Brown SB (2002) The advantages of aminolevulinic acid photodynamic therapy in dermatology. J Dermatolog Treat 13[Suppl 1]:S3-11
32. Weihrauch M, Bader M, Lehnert G, Wittekind C, Tannapfel A, Wrbitzky R (2002) Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma. Int Arch Occup Environ Health 75:272-276
33. Wilde J, Teixeira P, Bramhall SR, Gunson B, Mutimer D, Mirza DF (2002) Liver transplantation in haemophilia. Br J Haematol 117:952-956
34. Wolf P (1999) Photodynamische therapie - grundlagen und klinische anwendung in der dermatologie. Deutsches Ärzteblatt 22:1493-1498
35. Wolfsen HC, Ng CS (2002) Cutaneous consequences of photodynamic therapy. Cutis 69:140-142
36. Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, Marcoval J, Serrano T, Botargues JM, Maner M, Rota R (2001) Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 7:971-975
37. Zenk W, Schleier P (2001) Laserfluoreszenzdiagnostik steigert Überlebensrate. Grundlagen, praktisches Vorgehen, Fallbeispiele. Laser J 1:6-10
38. Zenk W, Dietel W, Schleier P, Günzel S (1999) Visualizing carcinomas of the mouth cavity by stimulating synthesis of fluores-cent protoporphyrin IX. Mund Kiefer Gesichtschir 3:205-209